Shingrix®

(recombinant varicella zoster virus glycoprotein E antigen)

Digital Adherence Program

Program overview

This sponsored program aims to remind patients who have had dose 1 of the Shingrix vaccine for the prevention of shingles that they are due for dose 2.

Patients will receive a series of four messages over approximately four months to remind them that they are eligible for their second dose of the Shingrix vaccine.

When?

This program was first launched in November 2021, with the latest update released in October 2025.

For which patients?

Program messages will be delivered via the app and SMS to patients who have had dose 1 of Shingrix dispensed or dose 1 of the Shingrix vaccination recorded in MedAdvisor for Pharmacy. 

Click here to view a sample of the messages

Shingrix